Company news
OptiBiotix Health PLC news in 2018
OptiBiotix Health PLC's news releases, calls and decks from 2018, newest first.
Issue of Convertible Loan Notes by ProBiotix
December 14, 2018
SlImBiome® Medical agreement for Greece and Cyprus
December 4, 2018
SlimBiome Medical manufacturing agreement
November 29, 2018
SlimBiome® granted medical device status & CE mark
November 27, 2018
CholBiome® agreement for Greece and Cyprus
November 22, 2018
LPLDL® US manufacturing and supply agreement
October 9, 2018
Exercise of Options & Director's Dealing
October 8, 2018
Non-exclusive distribution agreement for SlimBiome
October 3, 2018
Distribution agreement for CholBiome®
September 26, 2018
Formation of ProBiotix Health Limited
September 24, 2018
Exercise of Warrants and Issue of Equity
September 10, 2018
OptiBiotix signs US pharmaceutical deal
September 4, 2018
Proposed directorate change
August 6, 2018
Director's dealing
July 31, 2018
Agreement with global corporate for SweetBiotix®
June 26, 2018
Exclusive license agreement for LPLDL®
June 21, 2018
Manufacturing agreement with Morley Foods
June 18, 2018
Exercise of Options and Issue of Equity
June 14, 2018
US launch of LPLDL® with Seed Health
June 7, 2018
SweetBiotix® agreement with global dairy company
May 31, 2018
Placing and Issue of Equity
May 30, 2018
LP-LDL agreement for USA
May 22, 2018
SlimBiome® wins award at Vitafoods 2018
May 18, 2018
Exclusive manufacturing and supply agreement
May 16, 2018
Launch of extended range of products at Vitafoods
May 8, 2018
LP-LDL? news media interest in USA
May 1, 2018
Notice of Results
April 30, 2018
SlimBiome non-exclusive UK distribution agreement
April 24, 2018
Appointment of Head of Online Sales and Marketing
April 19, 2018
CholBiome exclusive distribution agreement
April 18, 2018
New patent filings for SweetBiotix
April 5, 2018
Scientific and commerical update
March 27, 2018
Launch of Slimbiome in Nutri-bites
March 8, 2018
LPLDL® Exclusive European License Agreement
March 6, 2018
OptiBiotix Capital Reorganisation
February 28, 2018
Exercise of warrant and issue of equity
February 6, 2018
Result of Meeting
January 25, 2018
SweetBiotix® development: human taste studies
January 23, 2018
Presentation of data at European Conference
January 17, 2018
Shareholder Circular and Notice of General Meeting
January 8, 2018